
Letronat Tablet
Marketer
Natco Pharma Ltd
Salt Composition
Letrozole (2.5mg)
Overview Letronat Tablet
Femara tablets are indicated for the management of breast cancer in women who have passed menopause. This medication can be administered independently or in conjunction with other therapies, including surgical intervention or radiotherapy. It's also employed in advanced breast cancer to inhibit metastasis. Femara tablets may be consumed with or without food. Adherence to the prescribed dosage and duration is crucial for optimal therapeutic outcomes. Dosage frequency is determined by the specific indication. Your physician will personalize your treatment regimen to effectively manage your symptoms. Continuous use, as directed, is necessary. Commonly reported side effects include vasomotor flushes, tiredness, diaphoresis, and elevated cholesterol (hypercholesterolemia). Report any concerning or persistent side effects to your physician immediately; management strategies may be available. Prior to commencing treatment, inform your doctor of any pre-existing liver or kidney conditions, or a history of osteoporosis. Complete disclosure of all concurrent medications is essential, as drug interactions may compromise efficacy or alter the medication's mechanism of action. Notify your doctor if you are pregnant or lactating. Pre- and ongoing monitoring, including vitamin D levels and bone mineral density assessments, may be conducted via blood tests.
Primary Ingredients of Letronat Tablet
No text provided. Please provide the text you wish me to rephrase.
Uses of Letronat Tablet
Managing breast cancer
Major Benefits of Letronat Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Letronat Tablet whole; do not chew, crush, or divide it. While you can take it with or without food, consistency in timing is recommended.
Common Side effects of Letronat Tablet:
- Dizziness
- Fatigue
- Weakness
- Bone pain
- Back pain
- Night sweats
- Joint pain
- Nausea
- Osteoporosis
- Joint inflammation
- Weight gain
- Hot flushes
- Edema (swelling)
- Flushing (sense of warmth in the face, ears, neck and trunk)
- Diaphoresis
- Bone fracture
- Hypercholesterolemia (high cholesterol)
- Cough
- Shortness of breath
How to use Letronat Tablet:
Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. While Letronat Tablets can be taken with or without food, consistent timing is recommended for optimal efficacy.
How Letronat Tablet works:
Letronat tablets function as an aromatase inhibitor, reducing the body's estrogen production. This lowered estrogen level can impede or halt the progression of certain estrogen-dependent breast cancers.
SAFETY ADVICE
AlcoholSAFE
Letronat Tablet consumption alongside alcohol does not produce adverse reactions.
PregnancyUNSAFE
Use of Letronat Tablets is strongly contraindicated during pregnancy. Pregnant women should consult their physician; animal and human studies indicate substantial risks to fetal development.
Breast feedingUNSAFE
Lactation and Letronat tablets are incompatible. Evidence indicates potential infant toxicity from this medication.
DrivingUNSAFE
Taking Letronat Tablets may cause drowsiness, blurred vision, or dizziness. Refrain from driving if you experience these side effects.
KidneySAFE IF PRESCRIBED
Kidney disease does not necessitate a Letronat Tablet dosage change; its use is considered safe in such patients. Data on its use in end-stage kidney disease is however scant. Physician consultation is advised.
LiverCAUTION
Patients with liver impairment should use Letronat tablets cautiously, potentially requiring dose modification. Physician consultation is advised.
What if you forget to take Letronat Tablet :
Should you forget a Letronat Tablet dose, take it immediately. If your next dose is imminent, however, omit the missed dose and resume your usual schedule. Never take a double dose.
Facts to Know About Letronat Tablet
| Label | Value |
|---|---|
| Chemical Type | Diphenylmethane-based compound |
| Developing Habits | No. |
| Treatment Category | Cancer Medications |
